Cargando…
Direct Oral Anticoagulants or Standard Anticoagulant Therapy in Fragile Patients with Venous Thromboembolism
Background The efficacy and safety of the direct oral anticoagulants (DOACs) in fragile patients (age ≥ 75 years and/or creatinine clearance levels ≤ 50 mL/min and/or body weight ≤ 50kg) with venous thromboembolism (VTE) has not been evaluated. Methods We used the RIETE database to compare the rat...
Autores principales: | López-Núñez, Juan J., Pérez-Andrés, Ricard, Di Micco, Pierpaolo, Schellong, Sebastian, Gómez-Cuervo, Covadonga, Sahuquillo, Joan Carles, Ciammaichella, Maurizio, Morales, Maria del Valle, Bosevski, Marijan, Monreal, Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2019
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524917/ https://www.ncbi.nlm.nih.gov/pubmed/31249985 http://dx.doi.org/10.1055/s-0039-1683970 |
Ejemplares similares
-
Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism
por: Moustafa, Farès, et al.
Publicado: (2017) -
Platelet Count and Bleeding in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism: Lesson from the RIETE Registry
por: Di Micco, Pierpaolo, et al.
Publicado: (2019) -
Sex Differences in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism
por: Blanco-Molina, Angeles, et al.
Publicado: (2014) -
D-dimer levels during and after anticoagulation withdrawal in patients with venous thromboembolism treated with non-vitamin K anticoagulants
por: Legnani, Cristina, et al.
Publicado: (2019) -
Venous Thromboembolism – Current Diagnostic and Treatment Modalities
por: Bosevski, Marijan, et al.
Publicado: (2016)